{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:22:00Z","timestamp":1791393720619,"version":"4.3.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,3]]},"DOI":"10.7759\/cureus.85288","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T14:42:51Z","timestamp":1748961771000},"source":"Crossref","is-referenced-by-count":3,"title":["Comprehensive Cytokine Gene Expression and Multiplex Analysis in Breast Cancer Patients: Insights Into Immune Profiles and Prognostic Factors\u2019 Association"],"prefix":"10.7759","author":[{"given":"Anisha","family":"Raju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuvaje","family":"Thriveni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankaranand S","family":"Bharatnur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00071-1","article-title":"The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases","volume":"22","author":"Anderson BO","year":"2021","unstructured":"Anderson BO, Ilbawi AM, Fidarova E, Weiderpass E, Stevens L, Abdel-Wahab M, Mikkelsen B. The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases. Lancet Oncol. 2021, 22:578-81. 10.1016\/S1470-2045(21)00071-1","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00660-9","article-title":"Beyond genetics: driving cancer with the tumour microenvironment behind the wheel","volume":"24","author":"Yuan S","year":"2024","unstructured":"Yuan S, Almagro J, Fuchs E. Beyond genetics: driving cancer with the tumour microenvironment behind the wheel. Nat Rev Cancer. 2024, 24:274-86. 10.1038\/s41568-023-00660-9","journal-title":"Nat Rev Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094832","article-title":"Exploring the immunological profile in breast cancer: recent advances in diagnosis and prognosis through circulating tumor cells","volume":"25","author":"Kotsifaki A","year":"2024","unstructured":"Kotsifaki A, Maroulaki S, Armakolas A. Exploring the immunological profile in breast cancer: recent advances in diagnosis and prognosis through circulating tumor cells. Int J Mol Sci. 2024, 25:4832. 10.3390\/ijms25094832","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-80962-1_25-1","article-title":"Pro-tumorigenic and anti-tumorigenic roles of pro-inflammatory cytokines in cancer","author":"Tahmasebi S","year":"2022","unstructured":"Tahmasebi S, Alimohammadi M, Khorasani S, Rezaei N. Pro-tumorigenic and anti-tumorigenic roles of pro-inflammatory cytokines in cancer. Handbook of Cancer and Immunology. Rezaei N (ed): Springer, Cham, Switzerland; 2022. 1-25. 10.1007\/978-3-030-80962-1_25-1"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020248","article-title":"Gene expression profiling in early breast cancer\u2014patient stratification based on molecular and tumor microenvironment features","volume":"10","author":"Munk\u00e1csy G","year":"2022","unstructured":"Munk\u00e1csy G, Santarpia L, Gy\u0151rffy B. Gene expression profiling in early breast cancer\u2014patient stratification based on molecular and tumor microenvironment features. Biomedicines. 2022, 10:248. 10.3390\/biomedicines10020248","journal-title":"Biomedicines"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2016.12.021","article-title":"Comparison of multiplex platforms for cytokine assessments and their potential use for biomarker profiling in multiple sclerosis","volume":"91","author":"Malekzadeh A","year":"2017","unstructured":"Malekzadeh A, Twaalfhoven H, Wijnstok NJ, Killestein J, Blankenstein MA, Teunissen CE. Comparison of multiplex platforms for cytokine assessments and their potential use for biomarker profiling in multiple sclerosis. Cytokine. 2017, 91:145-52. 10.1016\/j.cyto.2016.12.021","journal-title":"Cytokine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2018.07.021","article-title":"Patterns of relative telomere length is associated with hTERT gene expression in the tissue of patients with breast cancer","volume":"19","author":"Thriveni K","year":"2019","unstructured":"Thriveni K, Raju A, Kumar RV, Krishnamurthy S, Chaluvarayaswamy R. Patterns of relative telomere length is associated with hTERT gene expression in the tissue of patients with breast cancer. Clin Breast Cancer. 2019, 19:27-34. 10.1016\/j.clbc.2018.07.021","journal-title":"Clin Breast Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold M","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, et al.. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022, 66:15-23. 10.1016\/j.breast.2022.08.010","journal-title":"Breast"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6014","article-title":"High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patients","volume":"12","author":"Morrow E","year":"2023","unstructured":"Morrow E, Pennel K, Hatthakarnkul P, et al.. High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patients. Cancer Med. 2023, 12:13225-40. 10.1002\/cam4.6014","journal-title":"Cancer Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081999","article-title":"Dissecting tumor-immune microenvironment in breast cancer at a spatial and multiplex resolution","volume":"14","author":"Tzoras E","year":"2022","unstructured":"Tzoras E, Zerdes I, Tsiknakis N, et al.. Dissecting tumor-immune microenvironment in breast cancer at a spatial and multiplex resolution. Cancers (Basel). 2022, 14:1999. 10.3390\/cancers14081999","journal-title":"Cancers (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3340","article-title":"Biomarker discovery in patients with immunotherapy-treated melanoma with imaging mass cytometry","volume":"27","author":"Martinez-Morilla S","year":"2021","unstructured":"Martinez-Morilla S, Villarroel-Espindola F, Wong PF, et al.. Biomarker discovery in patients with immunotherapy-treated melanoma with imaging mass cytometry. Clin Cancer Res. 2021, 27:1987-96. 10.1158\/1078-0432.CCR-20-3340","journal-title":"Clin Cancer Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12764","article-title":"A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment","volume":"14","author":"Viratham Pulsawatdi A","year":"2020","unstructured":"Viratham Pulsawatdi A, Craig SG, Bingham V, et al.. A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment. Mol Oncol. 2020, 14:2384-402. 10.1002\/1878-0261.12764","journal-title":"Mol Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2021.03.016","article-title":"Applicability of spatial transcriptional profiling to cancer research","volume":"81","author":"Bassiouni R","year":"2021","unstructured":"Bassiouni R, Gibbs LD, Craig DW, Carpten JD, McEachron TA. Applicability of spatial transcriptional profiling to cancer research. Mol Cell. 2021, 81:1631-9. 10.1016\/j.molcel.2021.03.016","journal-title":"Mol Cell"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.09.015","article-title":"Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin","volume":"40","author":"Foster DS","year":"2022","unstructured":"Foster DS, Januszyk M, Delitto D, et al.. Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin. Cancer Cell. 2022, 40:1392-406.e7. 10.1016\/j.ccell.2022.09.015","journal-title":"Cancer Cell"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2869","article-title":"Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry","volume":"11","author":"Giesen C","year":"2014","unstructured":"Giesen C, Wang HA, Schapiro D, et al.. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Methods. 2014, 11:417-22. 10.1038\/nmeth.2869","journal-title":"Nat Methods"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abi5072","article-title":"Spatially mapping the immune landscape of melanoma using imaging mass cytometry","volume":"7","author":"Moldoveanu D","year":"2022","unstructured":"Moldoveanu D, Ramsay L, Lajoie M, et al.. Spatially mapping the immune landscape of melanoma using imaging mass cytometry. Sci Immunol. 2022, 7:eabi5072. 10.1126\/sciimmunol.abi5072","journal-title":"Sci Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-021-00301-w","article-title":"Three-dimensional imaging mass cytometry for highly multiplexed molecular and cellular mapping of tissues and the tumor microenvironment","volume":"3","author":"Kuett L","year":"2022","unstructured":"Kuett L, Catena R, \u00d6zcan A, et al.. Three-dimensional imaging mass cytometry for highly multiplexed molecular and cellular mapping of tissues and the tumor microenvironment. Nat Cancer. 2022, 3:122-33. 10.1038\/s43018-021-00301-w","journal-title":"Nat Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2599","article-title":"Multiplexed (18-plex) measurement of signaling targets and cytotoxic T cells in trastuzumab-treated patients using imaging mass cytometry","volume":"25","author":"Carvajal-Hausdorf DE","year":"2019","unstructured":"Carvajal-Hausdorf DE, Patsenker J, Stanton KP, et al.. Multiplexed (18-plex) measurement of signaling targets and cytotoxic T cells in trastuzumab-treated patients using imaging mass cytometry. Clin Cancer Res. 2019, 25:3054-62. 10.1158\/1078-0432.CCR-18-2599","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abk1692","article-title":"Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapy","volume":"7","author":"Hoch T","year":"2022","unstructured":"Hoch T, Schulz D, Eling N, G\u00f3mez JM, Levesque MP, Bodenmiller B. Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapy. Sci Immunol. 2022, 7:eabk1692. 10.1126\/sciimmunol.abk1692","journal-title":"Sci Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.666233","article-title":"High dimensional imaging mass cytometry panel to visualize the tumor immune microenvironment contexture","volume":"12","author":"Elaldi R","year":"2021","unstructured":"Elaldi R, Hemon P, Petti L, et al.. High dimensional imaging mass cytometry panel to visualize the tumor immune microenvironment contexture. Front Immunol. 2021, 12:666233. 10.3389\/fimmu.2021.666233","journal-title":"Front Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02534","article-title":"A 40-marker panel for high dimensional characterization of cancer immune microenvironments by imaging mass cytometry","volume":"10","author":"Ijsselsteijn ME","year":"2019","unstructured":"Ijsselsteijn ME, van der Breggen R, Farina Sarasqueta A, Koning F, de Miranda NF. A 40-marker panel for high dimensional characterization of cancer immune microenvironments by imaging mass cytometry. Front Immunol. 2019, 10:2534. 10.3389\/fimmu.2019.02534","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39762-1","article-title":"Cancer-associated fibroblast classification in single-cell and spatial proteomics data","volume":"14","author":"Cords L","year":"2023","unstructured":"Cords L, Tietscher S, Anzeneder T, Langwieder C, Rees M, de Souza N, Bodenmiller B. Cancer-associated fibroblast classification in single-cell and spatial proteomics data. Nat Commun. 2023, 14:4294. 10.1038\/s41467-023-39762-1","journal-title":"Nat Commun"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/365464-comprehensive-cytokine-gene-expression-and-multiplex-analysis-in-breast-cancer-patients-insights-into-immune-profiles-and-prognostic-factors-association","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T14:42:52Z","timestamp":1748961772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/365464-comprehensive-cytokine-gene-expression-and-multiplex-analysis-in-breast-cancer-patients-insights-into-immune-profiles-and-prognostic-factors-association"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.85288","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}